Abstracts by keywords: health policy
Ausgaben für pharmazeutische Innovationen werden weitgehend als Kosten gesehen – und das umso mehr, je größer die Finanzprobleme in der GKV sind. So werden auch im ersten Bericht der Finanzkommission Gesundheit vom 30. März 2026 Arzneimittel als Kostentreiber gesehen.1 Auch der Kabinettsentwurf für ein GKV-Beitragssatzstabilisierungsgesetz (BStabG) verfällt in alte Muster und sieht deutliche Einsparungen bei […]
03.08.2026
In medical practices, patients are increasingly being offered individual health services (IGeL). These services are to be paid for by the insured persons themselves, as they are outside the range of services provided by statutory health insurance. It is important for patients to be well informed about the benefits and possible harm of these medical measures before using an IGeL. It is also important that independent information on IGeL services is available. For this reason, the medical service of the National Association of Statutory Health Insurance Funds has launched the "IGeL Monitor" evaluation portal, in which evaluations of frequently offered IGeL services and further information on the IGeL services are published. In the article, the development of the IGeL market is presented, the information platform IGeL-Monitor and its evaluation results are presented and, based on this, some conclusions are drawn for dealing with IGeL services. Above all, the responsibility of the medical profession when selling IGeL services is emphasized and recommendations are given for patients on how to deal with IGeL offers.
31.03.2015
Health care research and health care reality are closely intertwined. A constituent part of health services research is to analyze, evaluate and contribute to optimization of the reality of care. This is particularly important in the context of statutory health insurance. The implementation and optimization of care models is one of the core tasks of a health insurance company. Scientific evidence and health care management thus form a quasi-natural unit. The implementation of the findings from health services research into everyday care provides a direct benefit for those insured by the health insurance company as well as for the statutory health insurance.
24.02.2012
Cost-effectiveness analysis has experienced enormous growth in recent years as an aid to decision-making. Their legal anchoring in the performance audit means that the reliability of the statements must be checked. Political and methodological skepticism is particularly directed against a simple decision based on the monetary costs per QALY of a therapy. The discussion is also growing as to whether subjective assessments of benefits by individuals should take precedence over objective assessments of a group. It is still unclear which controls will ultimately be chosen in the healthcare system. However, both approaches require methodological refinement before they can offer helpful support to health policy.